Study links full-fat cheese to lower dementia risk

A new study tracking over 27,000 Swedes for 25 years suggests that consuming more full-fat cheese and cream may reduce the risk of dementia. Participants eating higher amounts of these dairy products developed dementia less frequently than those who ate little or none. However, the findings indicate an association, not causation, and apply specifically to high-fat varieties.

Published on December 17, 2025, in the journal Neurology, the study examined dietary habits and dementia outcomes among 27,670 adults in Sweden, who were around 58 years old at the start. Over the 25-year follow-up, 3,208 participants were diagnosed with dementia. Researchers analyzed food intake records, including weekly consumption logs and frequency questions, to assess dairy patterns.

High-fat cheeses, defined as those with more than 20% fat like cheddar, Brie, and Gouda, showed a notable link. Those consuming 50 grams or more daily—equivalent to about two slices of cheddar—had a 13% lower dementia risk compared to those eating less than 15 grams, after adjusting for age, sex, education, and diet quality. Dementia rates were 10% in the higher-intake group versus 13% in the lower. The association was strongest for vascular dementia, with a 29% risk reduction. For Alzheimer's, the benefit appeared only in individuals without the APOE e4 genetic variant.

Similarly, daily intake of at least 20 grams of high-fat cream—such as whipping or double cream with 30-40% fat, about 1.4 tablespoons—correlated with a 16% lower dementia risk compared to none. No such patterns emerged for low-fat cheese, low-fat cream, milk (high- or low-fat), butter, or fermented products like yogurt.

"For decades, the debate over high-fat versus low-fat diets has shaped health advice, sometimes even categorizing cheese as an unhealthy food to limit," said lead researcher Emily Sonestedt, PhD, from Lund University. "Our study found that some high-fat dairy products may actually lower the risk of dementia, challenging some long-held assumptions about fat and brain health."

Sonestedt added, "These findings suggest that when it comes to brain health not all dairy is equal." The study, funded by Swedish organizations including the Swedish Research Council, highlights limitations: all participants were Swedish, where cheese is often eaten uncooked, unlike in places like the United States. Further research is needed to confirm if these foods protect brain health across populations.

Related Articles

Illustration of scientists analyzing genetic data linking lower cholesterol to reduced dementia risk in a lab setting.
Image generated by AI

Genetic study links lower cholesterol to reduced dementia risk

Reported by AI Image generated by AI Fact checked

A large-scale genetic analysis of about 1.09 million people suggests that lifelong, genetically lower cholesterol—specifically non‑HDL cholesterol—is associated with substantially reduced dementia risk. Using Mendelian randomization to emulate the effects of cholesterol‑lowering drug targets such as those for statins (HMGCR) and ezetimibe (NPC1L1), the study found up to an approximately 80% lower risk per 1 mmol/L reduction for some targets. ([research-information.bris.ac.uk](https://research-information.bris.ac.uk/en/publications/cholesterollowering-drug-targets-reduce-risk-of-dementia-mendelia?utm_source=openai))

A Swedish study suggests that consuming more high-fat cheese could lower dementia risk by 13%, based on data from nearly 30,000 people followed for 25 years. However, experts caution that it is an observational analysis without proof of causality. Critics highlight potential confounders and the importance of factors like blood pressure and weight control.

Reported by AI

A new genetic study indicates that obesity and high blood pressure directly contribute to dementia, beyond merely raising its risk. Researchers from Denmark and the U.K. used advanced methods to establish this causal link, emphasizing prevention through weight and blood pressure management. The findings suggest early interventions could avert vascular-related dementia.

New research finds that blood biomarkers associated with Alzheimer’s disease increase significantly faster in people with obesity than in those without. Drawing on five years of data from 407 volunteers, the study suggests that blood tests can detect obesity‑related changes earlier than brain scans, underscoring obesity as a major modifiable risk factor for Alzheimer’s.

Reported by AI Fact checked

A new study in BMJ Mental Health suggests that drinking up to four cups of coffee a day is associated with slower biological aging in people with severe mental disorders, reflected in longer telomeres—chromosome caps linked to cellular aging. The observed difference in telomere length corresponds to roughly five extra years of biological youth compared with non-coffee drinkers, while higher intake shows no such benefit and may contribute to cellular stress.

Researchers at Brazil’s Federal University of ABC report a simple copper-chelating molecule that reduced beta-amyloid–linked pathology and improved memory in rats. The compound showed no detectable toxicity in preclinical tests and, based on computer modeling, is predicted to cross the blood–brain barrier. The team is seeking industry partners for clinical development.

Reported by AI Fact checked

A large study published in Neurology finds that impaired kidney function is linked to higher levels of Alzheimer’s biomarkers in the blood, without increasing overall dementia risk. However, among people who already have elevated biomarker levels, poor kidney health may hasten when dementia symptoms appear, underscoring the need to factor kidney function into interpretation of Alzheimer’s blood tests.

 

 

 

This website uses cookies

We use cookies for analytics to improve our site. Read our privacy policy for more information.
Decline